The aim of the present study was to assess the extent to which elevation of MCP-1 production in muscle and elevated MCP-1 levels in plasma may be able to interfere with insulin signalling in skeletal muscle and promote insulin resistance. The gene discussed is CCL2; the disease is Insulin resistance.